Stockreport

Intensity Therapeutics regains compliance with Nasdaq's minimum bid price requirement [Seeking Alpha]

Intensity Therapeutics, Inc.  (INTS) 
PDF Nasdaq confirmed that for the last 10 consecutive business days, from February 19, 2026, through March 4, 2026, the closing bid price of the company's common stock was [Read more]